Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.62 is 157% above its 5-year average of 0.24, near the low end of its 5-year range (0.00–2.31).
As of the fiscal period ended Tuesday, June 30, 2026. 10.05% below its 12-month average of 0.69.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.62.
QUICK RATIO (ACID-TEST)
0.62
QUICK RATIO (ACID-TEST) AVG TTM
0.69
QUICK RATIO (ACID-TEST) AVG 3Y
0.32
QUICK RATIO (ACID-TEST) AVG 5Y
0.24
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.05%
CURRENT VS 3Y AVG
+97.08%
CURRENT VS 5Y AVG
+156.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 756 covered companies
CURRENT VS SECTOR MEDIAN
-80.53%
vs the sector median at left
Jupiter Neurosciences, Inc.
Market Cap
$1.20M
Quick Ratio (Acid-Test)
0.62
TTM Avg
0.69
3Y Avg
0.32
5Y Avg
0.24
Market Cap
$1.18M
Quick Ratio (Acid-Test)
2.55
TTM Avg
2.02
3Y Avg
1.02
5Y Avg
0.68
Market Cap
$1.15M
Quick Ratio (Acid-Test)
0.46
TTM Avg
0.56
3Y Avg
0.51
5Y Avg
1.01
Market Cap
$1.10M
Quick Ratio (Acid-Test)
3.75
TTM Avg
3.27
3Y Avg
2.43
5Y Avg
2.43
Market Cap
$1.06M
Quick Ratio (Acid-Test)
4.31
TTM Avg
1.47
3Y Avg
1.08
5Y Avg
7.17
Market Cap
$1.03M
Quick Ratio (Acid-Test)
7.81
TTM Avg
0.12
3Y Avg
1.01
5Y Avg
1.01
Market Cap
$1.38M
Quick Ratio (Acid-Test)
3.00
TTM Avg
0.80
3Y Avg
7.12
5Y Avg
9.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.20M | 0.62 | 0.69 | 0.32 | 0.24 |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | 2.55 | 2.02 | 1.02 | 0.68 |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | 0.46 | 0.56 | 0.51 | 1.01 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | 3.75 | 3.27 | 2.43 | 2.43 |
| NewcelX Ltd. (NCEL)vs › | $1.33M | 0.32 | 1.73 | 1.61 | 1.48 |
| Genprex, Inc. (GNPX)vs › | $1.34M | 6.77 | 2.33 | 3.65 | 16.80 |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | 4.31 | 1.47 | 1.08 | 7.17 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | 7.81 | 0.12 | 1.01 | 1.01 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | 3.00 | 0.80 | 7.12 | 9.62 |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | 0.27 | 1.06 | 2.93 | 2.76 |
Quick Ratio
0.62
Excludes inventory
Current Ratio
0.66
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.62 |
| 2026-03-31 | 0.48 |
| 2025-12-31 | 0.63 |
| 2025-09-30 | 0.65 |
| 2025-06-30 | 1.07 |
| 2025-03-31 | 1.91 |
| 2024-12-31 | 2.31 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.01 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.00 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-06-30 | 0.09 |
| 2022-03-31 | 0.03 |
| 2021-12-31 | 0.08 |
| 2021-09-30 | 0.25 |
| 2021-06-30 | 0.19 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.13 |
| 2020-09-30 | 0.00 |
